Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jad.2021.07.070 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Commentary on Abernathy-Close et al: Study on Mupirocin Treatment in Cutaneous Lupus Erythematosus.
Arthritis Rheumatol
January 2025
Department of Pediatrics, Institute for Maternal and Child Health "IRCCS Burlo Garofolo", Trieste, Italy.
Novel Reassortants of Oropouche Virus (OROV) Are Causing Maternal-Fetal Infection During Pregnancy, Stillbirth, Congenital Microcephaly and Malformation Syndromes.
Genes (Basel)
January 2025
Perinatal Pathology Consulting, 490 Dogwood Valley Drive, Atlanta, GA 30342, USA.
Oropouche virus (OROV) is an orthobunyavirus endemic in the Brazilian Amazon that has caused numerous outbreaks of febrile disease since its discovery in 1955. During 2024, Oropouche fever spread from the endemic regions of Brazil into non-endemic areas and other Latin American and Caribbean countries, resulting in 13,014 confirmed infections. Similarly to other orthobunyaviruses, OROV can undergo genetic reassortment events with itself as well as other viruses.
View Article and Find Full Text PDFAppropriate maternal thyroid hormone levels: a crucial factor in protecting offspring's vascular health.
Hypertens Res
January 2025
Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Do mothers' socioeconomic factors affect children's sodium and potassium intake?
Hypertens Res
January 2025
Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.
Commentary on "Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth".
Mol Cancer
January 2025
Molecular Epidemiology (MOLE), Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
VTRNA2-1 is a polymorphically imprinted locus. The proportion of individuals with a maternally imprinted VTRNA2-1 locus is consistently approximately 75% in populations of European origin, with the remaining circa 25% having a non-methylated VTRNA2-1 locus. Recently, VTRNA2-1 hypermethylation at birth was suggested to be a precursor of paediatric acute lymphoblastic leukaemia with biomarker potential.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!